-
Mashup Score: 0RECOVERY trial finds that empagliflozin is not an effective treatment for patients hospitalised with COVID-19 - 1 year(s) ago
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that empagliflozin does not provide any benefit for patients hospitalised with COVID-19. The results of the empagliflozin evaluation are published on medRxiv and will be submitted to a leading peer-reviewed medical journal. The RECOVERY trial is the world’s largest randomised clinical trial of potential treatments for…
Source: www.recoverytrial.netCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1RECOVERY trial finds that empagliflozin is not an effective treatment for patients hospitalised with COVID-19 - 1 year(s) ago
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that empagliflozin does not provide any benefit for patients hospitalised with COVID-19. The results of the empagliflozin evaluation are published on medRxiv and will be submitted to a leading peer-reviewed medical journal. The RECOVERY trial is the world’s largest randomised clinical trial of potential treatments for…
Source: www.recoverytrial.netCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1RECOVERY trial finds that empagliflozin is not an effective treatment for patients hospitalised with COVID-19 - 1 year(s) ago
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that empagliflozin does not provide any benefit for patients hospitalised with COVID-19. The results of the empagliflozin evaluation are published on medRxiv and will be submitted to a leading peer-reviewed medical journal. The RECOVERY trial is the world’s largest randomised clinical trial of potential treatments for…
Source: www.recoverytrial.netCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0RECOVERY trial finds that empagliflozin is not an effective treatment for patients hospitalised with COVID-19 - 1 year(s) ago
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that empagliflozin does not provide any benefit for patients hospitalised with COVID-19. The results of the empagliflozin evaluation are published on medRxiv and will be submitted to a leading peer-reviewed medical journal. The RECOVERY trial is the world’s largest randomised clinical trial of potential treatments for…
Source: www.recoverytrial.netCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1New RECOVERY trial result: baricitinib reduces deaths in patients hospitalised with COVID-19 - 2 year(s) ago
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that baricitinib, an anti-inflammatory drug normally used to treat rheumatoid arthritis, reduces the risk of death when given to hospitalised patients with severe COVID-19. The benefit was in addition to those of dexamethasone and tocilizumab, two other anti-inflammatory treatments which have previously been shown to…
Source: www.recoverytrial.netCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Welcome - 2 year(s) ago
This national clinical trial aims to identify treatments that may be beneficial for adults hospitalised with confirmed COVID-19.
Source: www.recoverytrial.netCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 5Welcome - 2 year(s) ago
This national clinical trial aims to identify treatments that may be beneficial for adults hospitalised with confirmed COVID-19.
Source: www.recoverytrial.netCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 20New RECOVERY trial result: baricitinib reduces deaths in patients hospitalised with COVID-19 - 2 year(s) ago
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that baricitinib, an anti-inflammatory drug normally used to treat rheumatoid arthritis, reduces the risk of death when given to hospitalised patients with severe COVID-19. The benefit was in…
Source: www.recoverytrial.netCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 10Molnupiravir to be investigated by the RECOVERY Trial as a potential treatment for patients hospitalised with COVID-19 - 2 year(s) ago
From today, the RECOVERY Trial – the world’s largest study investigating potential COVID-19 treatments – will begin testing the antiviral treatment molnupiravir. The study is open to all patients hospitalised with severe COVID-19, and is taking place in 177 NHS hospital…
Source: www.recoverytrial.netCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 0Welcome - 2 year(s) ago
This national clinical trial aims to identify treatments that may be beneficial for adults hospitalised with confirmed COVID-19.
Source: www.recoverytrial.netCategories: Critical Care, Latest HeadlinesTweet
https://t.co/LzgYKUD1y8.